The post Aave DAO Community Clashes With Aave Labs Over CoW Swap Fees appeared on BitcoinEthereumNews.com. A dispute between the Aave decentralized autonomous organizationThe post Aave DAO Community Clashes With Aave Labs Over CoW Swap Fees appeared on BitcoinEthereumNews.com. A dispute between the Aave decentralized autonomous organization

Aave DAO Community Clashes With Aave Labs Over CoW Swap Fees

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

A dispute between the Aave decentralized autonomous organization (DAO), which governs the Aave decentralized finance (DeFi) protocol, and Aave Labs, the main development company for Aave products, over fees from the recently announced integration with decentralized exchange aggregator CoW Swap, continues to flare up.

The issue was raised by pseudonymous Aave DAO member EzR3aL, who said that the fees generated by crypto asset swaps using CoW Swap were going to a different onchain address, not the treasury of the Aave decentralized autonomous organization.

Instead, the fees are going to a private address controlled by Aave Labs. EzR3aL raised several questions, including why the DAO was not consulted before the fees were routed, and argued that the fees belong to the DAO.

The governance forum post that sparked the debate. Source: Aave Governance

“Another entity, rather than the Aave DAO, is receiving at least $200,000 per week worth of Ether,” EzR3aL said, adding that this amounts to $10 million of potential annual revenue kept from the DAO.

Aave Labs responded that the front-end components for the website and application interfaces have always been the rightful purview of Aave Labs.

Related: Aave launches retail savings app with up to 9% APY to compete with banks

Protocol-level changes, like interest rate policies and approving changes to smart contract code, have always been subject to the DAO’s stewardship, Aave Labs said.

Aave Labs also claimed that it was the entity that funded the development of the “adapters,” the lines of code that allow swaps and other integrations to work. 

The total value locked in the Aave protocol and a financial overview of the DeFi platform. Source: DeFiLlama

However, the response did little to curb the tension, with several DAO members saying that the Aave DAO funded the development of the original adapter technology; therefore, the revenue from the integration should flow back to the DAO.

Marc Zeller, the founder of the Aave-Chan Initiative, a delegate platform serving the Aave governance community, said the decision to route the fees exclusively to Aave Labs is “extremely concerning.”

“Aave Labs, in the pursuit of their own monetization, redirected Aave user volume towards competition. This is unacceptable,” Zeller said.

Cointelegraph reached out to Aave Labs but did not obtain an immediate response by the time of publication.

The conflict highlights the complexities of running a DAO, which is a novel form of governance and organization that has benefits over traditional business structures but also brings its own unique challenges. 

Magazine: The one thing these 6 global crypto hubs all have in common…

Source: https://cointelegraph.com/news/firestorm-erupts-aave-governance-cowswap-fees?utm_source=rss_feed&utm_medium=feed&utm_campaign=rss_partner_inbound

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09